Passive immunisation with IgG endotoxin core antibody hyperimmune fresh frozen plasma

被引:9
作者
HamiltonDavies, C
Barclay, GR
Murphy, WG
Machin, SJ
Webb, AR
机构
[1] UCL, SCH MED, DEPT HAEMATOL, LONDON W1N 8AA, ENGLAND
[2] ROYAL INFIRM, SCOTTISH NATL BLOOD TRANSFUS SERV, EDINBURGH & SE SCOTLAND REG TRANSFUS CTR, EDINBURGH, MIDLOTHIAN, SCOTLAND
关键词
D O I
10.1046/j.1423-0410.1996.7130165.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Postoperative complications have been associated with low pre-operative endotoxin core antibody (EndoCAb) status. Seventy-three patients scheduled to undergo elective cardiac surgery were screened for IgG EndoCAb levels 1 week prior to admission. Of these 73 patients, 39 had levels below the median of a healthy population (100 MU = median units/ml). Only 6 received an infusion of IgG EndoCAb hyperimmune fresh frozen plasma (FFP) due to surgical rescheduling or unavailability of compatible hyperimmune FFP. The 6 patients demonstrated significant elevation (p<0.0001) of their IgG EndoCAb levels from a mean level of 43 MU/ml (range: 26-75) to a posttransfusion mean of 267 MU/ml (range: 227-300), which persisted until at least immediately prior to the operative period. We conclude that passive immunisation with EndoCAb hyperimmune FFP is possible prior to elective surgery and that the kinetic profile of such an administration will allow the FFP to be given the night prior to surgery and still maintain significantly elevated levels for surgery planned the following morning.
引用
收藏
页码:165 / 169
页数:5
相关论文
共 17 条
[1]  
ANDERSEN LW, 1987, J THORAC CARDIOV SUR, V93, P115
[2]  
Barclay G R, 1995, Prog Clin Biol Res, V392, P263
[3]  
BARRON RL, 1993, CLIN PHARMACY, V12, P829
[4]   ENDOTOXEMIA IN HUMAN SEPTIC SHOCK [J].
DANNER, RL ;
ELIN, RJ ;
HOSSEINI, JM ;
WESLEY, RA ;
REILLY, JM ;
PARILLO, JE .
CHEST, 1991, 99 (01) :169-175
[5]   EFFECT OF HEMORRHAGIC-SHOCK ON BACTERIAL TRANSLOCATION, INTESTINAL MORPHOLOGY, AND INTESTINAL PERMEABILITY IN CONVENTIONAL AND ANTIBIOTIC-DECONTAMINATED RATS [J].
DEITCH, EA ;
MORRISON, J ;
BERG, R ;
SPECIAN, RD .
CRITICAL CARE MEDICINE, 1990, 18 (05) :529-536
[6]  
DEITCH EA, 1987, ARCH SURG-CHICAGO, V122, P185
[7]  
Fiddian-Green R G, 1990, Semin Thorac Cardiovasc Surg, V2, P389
[8]   NATURAL CYTOKINE ANTAGONISTS AND ENDOGENOUS ANTIENDOTOXIN CORE ANTIBODIES IN SEPSIS SYNDROME [J].
GOLDIE, AS ;
FEARON, KCH ;
ROSS, JA ;
BARCLAY, GR ;
JACKSON, RE ;
GRANT, IS ;
RAMSAY, G ;
BLYTH, AS ;
HOWIE, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (02) :172-177
[9]  
HAMILTONDAVIES C, 1995, BRIT J ANAESTH, V74, P34
[10]   INTRODUCTION OF NEW TECHNOLOGY INTO CRITICAL CARE PRACTICE - A HISTORY OF HA-1A HUMAN MONOCLONAL-ANTIBODY AGAINST ENDOTOXIN [J].
LUCE, JM .
CRITICAL CARE MEDICINE, 1993, 21 (08) :1233-1241